BIOVAIL Corp·4

Aug 10, 12:08 PM ET

Mayer Christine 4

4 · BIOVAIL Corp · Filed Aug 10, 2010

Insider Transaction Report

Form 4
Period: 2010-08-09
Mayer Christine
SVP,BTA Pharmaceuticals, Inc.
Transactions
  • Sale

    Common Stock, no par value

    2010-08-09$22.95/sh2,000$45,9002,000 total
  • Exercise/Conversion

    Stock Options (right to purchase)

    2010-08-0920,000255,333 total
    Exercise: $17.45From: 2009-08-03Exp: 2010-08-09Common Stock, no par value (20,000 underlying)
  • Sale

    Common Stock, no par value

    2010-08-09$22.90/sh2,000$45,80018,000 total
  • Sale

    Common Stock, no par value

    2010-08-09$22.93/sh2,000$45,8604,000 total
  • Sale

    Common Stock, no par value

    2010-08-09$22.96/sh2,000$45,9200 total
  • Exercise/Conversion

    Common Stock, no par value

    2010-08-09$17.45/sh+20,000$349,00020,000 total
  • Sale

    Common Stock, no par value

    2010-08-09$22.91/sh8,000$183,28010,000 total
  • Sale

    Common Stock, no par value

    2010-08-09$22.92/sh4,000$91,6806,000 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT